Bedside inflammatory mediators in pulmonary tuberculosis

Silica-Induced Inflammatory Mediators and Pulmonary Fibrosis

Silicosis continues to be a lung disease with significant morbidity and mortality. Although silicainduced lung injury and cell activation and/or death has been investigated over the past several years, basic research continues to reveal the cell: cell and cell: mediator interactions critical to these events. This Chapter will emphasize the production and participation of several inflammatory cy...

Cytotoxic Mediators in Paradoxical HIV–Tuberculosis Immune Reconstitution Inflammatory Syndrome

Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) frequently complicates combined antiretroviral therapy and antituberculosis therapy in HIV-1-coinfected tuberculosis patients. The immunopathological mechanisms underlying TB-IRIS are incompletely defined, and improved understanding is required to derive new treatments and to reduce associated morbidity and mortality....

Pulmonary Tuberculosis

A STUDY OF MYCOBACTERIUM TUBERCULOSIS DRUG RESISTANCE IN PULMONARY TUBERCULOSIS

Tuberculosis remains a major public health problem in both developing and developed countries. Drug-resistant tuberculosis is an increasing health problem and serious challenge to tuberculosis (TB) control programs. Information about the susceptibility pattern of Mycobacterium tuberculosis isolates against anti-tuberculosis drugs is an important aspect to TB control. The objectives of the s...

Radiological Dependence in Diagnosis of Pulmonary Tuberculosis

Introduction: Diagnosis of tuberculosis under the National Tuberculosis Control Program (NTCP) is based on microscopic examination of sputum. The main objective of this study was to assess the perception of physicians and patients regarding the importance of chest X-ray in diagnosing pulmonary tuberculosis with a view to suggest corrective measures. Materials & Methods: One hundred and eight...